| Literature DB >> 24927056 |
Phuhai Nguyen1, Nassima Oumata2, Flavie Soubigou1, Justine Evrard1, Nathalie Desban3, Pascale Lemoine4, Serge Bouaziz4, Marc Blondel1, Cécile Voisset1.
Abstract
Series of 6-aminophenanthridines and related heterocyclic compounds such as benzonaphtyridines were prepared. Reduction of one of the three aromatic rings was also performed. The compounds were first tested for their antiprion activity in a previously described yeast-based colourimetric prion assay. The most potent derivatives were then assayed ex vivo against the mammalian prion PrP(Sc) in a cell-based assay. Several of the new compounds were found more potent than the parent lead 6-aminophenanthridine. The most promising compounds against yeast and mammalian prions were 8-azido-6-aminophenanthridine (3m), and 7,10-dihydrophenanthridin-6-amine (14). In the mammalian cell-based assay, the IC50 of these two compounds were around 5 μM and 1.8 μM, respectively.Entities:
Keywords: Neurodegenerative diseases; Phenanthridine; Prions; Protein misfolding
Mesh:
Substances:
Year: 2014 PMID: 24927056 DOI: 10.1016/j.ejmech.2014.05.083
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514